The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Solubility of Cyclodextrins and Drug/Cyclodextrin Complexes
Open accessAbstract
Cyclodextrins (CDs), a group of oligosaccharides formed by glucose units bound together in a ring, show a promising ability to form complexes with drug molecules and improve their physicochemical properties without molecular modifications. The stoichiometry of drug/CD complexes is most frequently 1:1. However, natural CDs have a tendency to self-assemble and form aggregates in aqueous media. CD aggregation can limit their solubility. Through derivative formation, it is possible to enhance their solubility and complexation capacity, but this depends on the type of substituent and degree of substitution. Formation of water-soluble drug/CD complexes can increase drug permeation through biological membranes. To maximize drug permeation the amount of added CD into pharmaceutical preparation has to be optimized. However, solubility of CDs, especially that of natural CDs, is affected by the complex formation. The presence of pharmaceutical excipients, such as water-soluble polymers, preservatives, and surfactants, can influence the solubilizing abilities of CDs, but this depends on the excipients’ physicochemical properties. The competitive CD complexation of drugs and excipients has to be considered during formulation studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
Cyclodextrins and their uses: a review
Del Valle, E. M. M. (2004) · Process Biochemistry · doi:10.1016/s0032-9592(03)00258-9 · Cited by 3,375
Higuchi, T., & Connors, A. (1965) · Cited by 2,554
Cyclodextrin-based pharmaceutics: past, present and future
Davis, M. E., & Brewster, M. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1576 · Cited by 1,996
Cyclodextrins as pharmaceutical solubilizers
Brewster, M. E., & Loftsson, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.012 · Cited by 1,882
Self-citationCyclodextrins and their pharmaceutical applications
LOFTSSON, T., & DUCHENE, D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,764
Self-citationHiguchi, T. (1965) · Cited by 1,143
A review on the use of cyclodextrins in foods
Astray, G., Gonzalez-Barreiro, C., Mejuto, J. C., Rial-Otero, R., & Simal-Gándara, J. (2009) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2009.01.001 · Cited by 911
Kurkov, S. V., & Loftsson, T. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.06.055 · Cited by 831
Self-citationCyclodextrins: structure, physicochemical properties and pharmaceutical applications
Jansook, P., Ogawa, N., & Loftsson, T. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.018 · Cited by 811
Self-citationCyclodextrins in drug delivery
Loftsson, T., Jarho, P., Másson, M., & Järvinen, T. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.335 · Cited by 793
Self-citationCyclodextrin-Based Host–Guest Supramolecular Nanoparticles for Delivery: From Design to Applications
Hu, Q.-D., Tang, G.-P., & Chu, P. K. (2014) · Accounts of Chemical Research · doi:10.1021/ar500055s · Cited by 525
Physical chemical analysis of percutaneous absorption process from creams and ointments.
Higuchi, T. (1960) · Medical Entomology and Zoology · Cited by 464
Mechanisms of drug release from cyclodextrin complexes
Stella, V. J., Rao, V. M., Zannou, E. A., & Zia, V. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00052-0 · Cited by 442
Jambhekar, S. S., & Breen, P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.11.017 · Cited by 383
Self-assembled cyclodextrin aggregates and nanoparticles
Messner, M., Kurkov, S. V., Jansook, P., & Loftsson, Þ. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.11.035 · Cited by 327
Self-citationEffects of Cyclodextrins on Drug Delivery Through Biological Membranes
Loftsson, T., Vogensen, S. B., Brewster, M. E., & Konráðsdóttir, F. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20992 · Cited by 302
Self-citationSelf‐Association and Cyclodextrin Solubilization of Drugs
Loftsson, T., Magnúsdóttir, A., Másson, M., & Sigurjónsdóttir, J. F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10226 · Cited by 277
Self-citationKiss, T., Fenyvesi, F., Bácskay, I., Váradi, J., Fenyvesi, É., Iványi, R., Szente, L., Tósaki, Á., & Vecsernyés, M. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.04.014 · Cited by 203
Cyclodextrin‐Based Formulations: A Non‐Invasive Platform for Targeted Drug Delivery
Muankaew, C., & Loftsson, T. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12917 · Cited by 203
Self-citationStudy to explore the mechanism to form inclusion complexes of β-cyclodextrin with vitamin molecules
Saha, S., Roy, A., Roy, K., & Roy, M. N. (2016) · Scientific Reports · doi:10.1038/srep35764 · Cited by 201
The effect of water-soluble polymers on drug-cyclodextrin complexation
Loftsson, T., Frikdriksdóttir, H., Sigurkdardóttir, A. M., & Ueda, H. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90155-4 · Cited by 192
Self-citationCyclodextrins and ternary complexes: technology to improve solubility of poorly soluble drugs
Miranda, J. C. D., Martins, T. E. A., Veiga, F., & Ferraz, H. G. (2011) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502011000400003 · Cited by 190
Loftsson, Þ., Moya‐Ortega, M. D., Alvarez‐Lorenzo, C., & Concheiro, Á. (2015) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12427 · Cited by 124
Cyclodextrin-Lipid Complexes: Cavity Size Matters
Szente, L., & Fenyvesi, É. (2016) · Structural Chemistry · doi:10.1007/s11224-016-0884-9 · Cited by 123
Cyclodextrins and the Biopharmaceutics Classification System of Drugs
Loftsson, Þ. (2002) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1023/a:1023088423667 · Cited by 121
Leclercq, L., Bricout, H., Tilloy, S., & Monflier, É. (2006) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2006.12.001 · Cited by 90
Savolainen, J., Järvinen, K., Taipale, H., et al. (1998) · Pharmaceutical Research · doi:10.1023/a:1011900527021 · Cited by 88
Deprotonation of β-cyclodextrin in alkaline solutions
Gaidamauskas, E., Norkus, E., Butkus, E., Crans, D. C., & Grincienė, G. (2008) · Carbohydrate Research · doi:10.1016/j.carres.2008.10.025 · Cited by 83
Inclusion complexation of ziprasidone mesylate with β-cyclodextrin sulfobutyl ether
Kim, Y., Oksanen, D. A., Massefski, W. W., Blake, J. F., Duffy, E. M., & Chrunyk, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980109t · Cited by 80
Loftsson, Þ. (1998) · PubMed · Cited by 74
Müller, B. W., & Albers, E. (1991) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600800620 · Cited by 71
Müller, B. W., & Brauns, U. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750609 · Cited by 70
Yong, C. W., Washington, C., & Smith, W. R. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9506-y · Cited by 65
Wenz, G. (2012) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.8.218 · Cited by 57
Interactions between preservatives and 2-hydroxypropyl-β-cyclodextrin
Loftsson, Þ., Stefánsdóttir, Ó., Friôriksdóttir, H., & Guomundsson, O. (1992) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049209040853 · Cited by 56
Lumholdt, L., Holm, R., Jørgensen, E. B., & Larsen, K. L. (2012) · Carbohydrate Research · doi:10.1016/j.carres.2012.09.018 · Cited by 56
In vitro action of human and porcine α-amylases on cyclomalto-oligosaccharides
Kondo, H. G., Nakatani, H., & Hiromi, K. (1990) · Carbohydrate Research · doi:10.1016/0008-6215(90)84036-t · Cited by 54
Azarbayjani, A. F., Lin, H., Yap, C. W., Chan, Y. W., & Chan, S. Y. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.06.0014 · Cited by 48
Hirayama, F., Mieda, S., Miyamoto, Y., Arima, H., & Uekama, K. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js990128i · Cited by 33
Kurkov, S. V., Madden, D., Carr, D. B., et al. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23329 · Cited by 29
Li, H., Ge, J., Guo, T., Yang, S., He, Z., York, P., Sun, L., Xu, X., & Zhang, J. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.07.010 · Cited by 18
Holm, R., Olesen, N. E., Alexandersen, S. D., Dahlgaard, B. N., Westh, P., & Mu, H. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.09.011 · Cited by 12
Wang, C., Wang, X., Xu, X., Liu, B., Xu, X., Sun, L., Li, H., & Zhang, J. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2015.12.026 · Cited by 11
Cited by
Cyclodextrins: Structural, Chemical, and Physical Properties, and Applications
Poulson, B. G., Alsulami, Q. A., Sharfalddin, A., El Agammy, E. F., Mouffouk, F., Emwas, A.-H., Jaremko, L., & Jaremko, M. (2021) · Polysaccharides · doi:10.3390/polysaccharides3010001 · Cited by 312
Nanonization techniques to overcome poor water-solubility with drugs
Da Silva, F. L. O., Marques, M. B. D. F., Kato, K. C., & Carneiro, G. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1750591 · Cited by 136
Metadata
- Authors
- Saokham, P., Muankaew, C., Jansook, P., & Loftsson, T.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2018-05-11
- Volume
- 23
- Issue
- 5
- Pages
- 1161
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2800612483
- Cited by
- 727
- References
- 45
- FWCI
- 20.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.